Oscor Launches Destino Steerable Guiding Sheath
Oscor receives FDA, Canada and CE mark clearance in September 2012 on the next-generation steerable guiding sheath, the Destino.
The Oscor Destino is the first and only steerable guiding sheath, which offers 180° bidirectional steering and is available in several curves (small, medium, large) and sheath length combinations (from 45 cm to 90 cm). Other features include a next generation hemostatic valve with a side port and an ergonomically designed soft grip handle which provides more precise steering control.
The Destino sheath is approved for use in procedures that involve the delivery of catheters and other therapeutic devices into the cardiovascular system, including transseptal access. Available in several sizes, from 8.5 French to 12 French shaft inner diameter, the Destino is an ideal tool that enables any catheter to become steerable, simply by inserting it into the Destino sheath, and delivering it to the target location.
Oscor, Inc. is a privately held company which develops medical technology and services that focus on providing physicians with the best tools to improve patient’s quality of life, while reducing risk, trauma, cost, procedure time and need for aftercare.
Oscor is headquartered in Palm Harbor, Florida. and has four major focus areas that include cardiac rhythm management, atrial fibrillation, cardiology and radiology. For more information, please visit www.oscor.com.